SeaStar Medical Holding Corp (NASDAQ: ICU) has experienced a rise in its stock price by 29.48 compared to its previous closing price of 1.73. However, the company has seen a gain of 42.68% in its stock price over the last five trading days. globenewswire.com reported 2025-01-22 that DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Mayo Clinic is now cleared to enroll subjects in the company’s NEUTRALIZE-AKI pivotal trial, increasing the number of activated sites to 15.
Is It Worth Investing in SeaStar Medical Holding Corp (NASDAQ: ICU) Right Now?
The 36-month beta value for ICU is also noteworthy at -1.04. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ICU is 4.29M, and at present, short sellers hold a 9.71% of that float. The average trading volume of ICU on February 03, 2025 was 266.75K shares.
ICU’s Market Performance
The stock of SeaStar Medical Holding Corp (ICU) has seen a 42.68% increase in the past week, with a 12.00% rise in the past month, and a -33.13% fall in the past quarter. The volatility ratio for the week is 23.65%, and the volatility levels for the past 30 days are at 11.45% for ICU. The simple moving average for the past 20 days is 21.54% for ICU’s stock, with a -60.31% simple moving average for the past 200 days.
ICU Trading at 10.42% from the 50-Day Moving Average
After a stumble in the market that brought ICU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.78% of loss for the given period.
Volatility was left at 11.45%, however, over the last 30 days, the volatility rate increased by 23.65%, as shares surge +15.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.28% upper at present.
During the last 5 trading sessions, ICU rose by +42.68%, which changed the moving average for the period of 200-days by -86.48% in comparison to the 20-day moving average, which settled at $1.84. In addition, SeaStar Medical Holding Corp saw 15.46% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICU starting from Chung Kevin, who purchase 4,250 shares at the price of $1.99 back on Nov 18 ’24. After this action, Chung Kevin now owns 13,685 shares of SeaStar Medical Holding Corp, valued at $8,458 using the latest closing price.
Chung Kevin, the Chief Medical Officer of SeaStar Medical Holding Corp, purchase 1,000 shares at $4.26 during a trade that took place back on Sep 30 ’24, which means that Chung Kevin is holding 9,435 shares at $4,258 based on the most recent closing price.
Stock Fundamentals for ICU
Current profitability levels for the company are sitting at:
- -235.56 for the present operating margin
- 1.0 for the gross margin
The net margin for SeaStar Medical Holding Corp stands at -445.38. The total capital return value is set at 7.81.
Currently, EBITDA for the company is -11.14 million with net debt to EBITDA at 0.07. When we switch over and look at the enterprise to sales, we see a ratio of 116.4. The receivables turnover for the company is 1.0for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.54.
Conclusion
In summary, SeaStar Medical Holding Corp (ICU) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
